News
Singapore's national platform for drug discovery and development, has announced the presentation of updated clinical data for ...
Cancer patients care forced to call pharmacies across the UK to hunt down medication or face skipping meals in what some are ...
Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...
CHICAGO -- A neoadjuvant chemotherapy regimen of cisplatin (Platinol), nab-paclitaxel (Abraxane), capecitabine (Xeloda), and ...
20h
TipRanks on MSNNovocure data support pancreatic cancer approval, says Wells FargoW ells Fargo is “encouraged” by Novocure’s ASCO presentation, saying the data and panel were generally positive on PANOVA-3 and tumor treating fields for pancreatic cancer.
1d
Medical Device Network on MSNEU Shield consortium launches to cut pancreatic cancer mortality rateThe new consortium aims to bolster the five-year survival rate of high-risk pancreatic cancer patients from 10% to 30% by ...
Actuate Therapeutics has set its sights on getting elraglusib approved for pancreatic cancer after the glycogen synthase ...
Annual Meeting, multiple companies presented clinical trial data showing their drugs and devices helped patients with pancreatic cancer live longer or improve their ability to respond to treatment.
CT scans are quick, painless, non-invasive tests that can identify everything from brain tumors to injuries from an accident. But a new study published in the journal JAMA Internal Medicine shows a ...
New data show improved outcomes in resectable pancreatic cancer with PAXG chemotherapy over standard mFOLFIRINOX, but should ...
In the phase 3 PANOVA-3 trial, patients who underwent tumor-treating fields therapy had extended overall survival vs standard ...
A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results